HealthTronics OssaTron Market Expands 10-Fold With Tennis Elbow Indication
This article was originally published in The Gray Sheet
Executive Summary
FDA approval of HealthTronics' OssaTron high-energy shockwave device for "tennis-elbow" treatment gives the company access to the U.S. general orthopedics market, which includes about 20,000 practices, according to the firm
You may also be interested in...
Siemens Sonocur Swings Approval: Low Energy Level Touted For Tennis Elbow
Siemens is highlighting a statistically significant pain reduction rate (50%) in nearly two-thirds (64%) of patients using the Sonocur Basic low-energy extracorporeal shockwave therapy system for lateral epicondylitis, or "tennis elbow.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.